Key points from article :
Atlas Biomed, a London-based DNA-testing company, has abruptly ceased operations, leaving customers concerned about the security of their sensitive genetic data. The company, known for providing insights into users' genetic makeup and predispositions to certain health conditions, has left users unable to access their personalized reports. Despite multiple inquiries, the company has not responded, and efforts by the BBC to contact them have been unsuccessful.
The Information Commissioner's Office (ICO) has confirmed a complaint about Atlas Biomed, emphasizing that organizations are expected to manage personal data securely. Experts suggest that this incident highlights the risks DNA-testing service users face, as they rely on these companies to protect highly sensitive information.
Atlas Biomed, registered in London's Silicon Roundabout tech hub, has possible ties to Russia, with company officers listed at a Moscow address. Although registered as active, it has not filed financial statements since December 2022, raising further questions. Notably, Atlas Biomed’s last updates on social media were in 2023, and its registered office shows no recent activity.
Cybersecurity experts have called attention to the Russian connections, describing them as unusual. Data privacy authorities emphasize the significance of safeguarding biometric data, which is unique and cannot be altered. This case underscores the critical need for transparency and responsibility in handling genetic data, as users depend on DNA-testing companies to maintain the security of their most personal information.
